Carrara, R. de Cássia Viu; Fontes, Aparecida Maria; Abraham, Kuruvilla Joseph 
; Orellana, M. D.; Haddad, S. K.; Palma, P. V. B.; Panepucci, R. A.; Zago, Marco Antonio; Covas, Dimas Tadeu
Source: Clinical and Translational Oncology. Unidades: FMRP, FFCLRP
Subjects: LEUCEMIA MIELOIDE, DOENÇA CRÔNICA, EXPRESSÃO GÊNICA, MICRORNAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CARRARA, R. de Cássia Viu et al. Expression differences of genes in the PI3K/AKT, WNT/b-catenin, SHH, NOTCH and MAPK signaling pathways in CD34+ hematopoietic cells obtained from chronic phase patients with chronic myeloid leukemia and from healthy controls. Clinical and Translational Oncology, v. 20, n. 4, p. 542-549, 2018Tradução . . Disponível em: https://doi.org/10.1007/s12094-017-1751-x. Acesso em: 09 nov. 2024.APA
Carrara, R. de C. V., Fontes, A. M., Abraham, K. J., Orellana, M. D., Haddad, S. K., Palma, P. V. B., et al. (2018). Expression differences of genes in the PI3K/AKT, WNT/b-catenin, SHH, NOTCH and MAPK signaling pathways in CD34+ hematopoietic cells obtained from chronic phase patients with chronic myeloid leukemia and from healthy controls. Clinical and Translational Oncology, 20( 4), 542-549. doi:10.1007/s12094-017-1751-xNLM
Carrara R de CV, Fontes AM, Abraham KJ, Orellana MD, Haddad SK, Palma PVB, Panepucci RA, Zago MA, Covas DT. Expression differences of genes in the PI3K/AKT, WNT/b-catenin, SHH, NOTCH and MAPK signaling pathways in CD34+ hematopoietic cells obtained from chronic phase patients with chronic myeloid leukemia and from healthy controls [Internet]. Clinical and Translational Oncology. 2018 ; 20( 4): 542-549.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1007/s12094-017-1751-xVancouver
Carrara R de CV, Fontes AM, Abraham KJ, Orellana MD, Haddad SK, Palma PVB, Panepucci RA, Zago MA, Covas DT. Expression differences of genes in the PI3K/AKT, WNT/b-catenin, SHH, NOTCH and MAPK signaling pathways in CD34+ hematopoietic cells obtained from chronic phase patients with chronic myeloid leukemia and from healthy controls [Internet]. Clinical and Translational Oncology. 2018 ; 20( 4): 542-549.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1007/s12094-017-1751-x
